Respiratory symptoms do not reflect functional impairment in early CF lung disease

Insa Korten1, Marc-Alexander Oestreich2, Urs Frey3

  • 1Division of Paediatric Respiratory Medicine and Allergology, Department of Paediatrics, Inselspital, Bern Unviersity Hospital, University of Bern, Switzerland.

Insights

Respiratory symptoms in infants with cystic fibrosis (CF) are not more frequent than in healthy infants during the first year of life. Early lung disease in CF may not be apparent through clinical symptoms alone.

Area of Science:

  • Pediatric Pulmonology
  • Neonatal Research
  • Genetic Disease Studies

Background:

  • Cystic Fibrosis (CF) can cause lung disease within the first year of life in infants.
  • The prevalence and intensity of infant respiratory symptoms in CF remain largely unknown.
  • Early detection of lung disease in CF infants is crucial for timely intervention.

Purpose of the Study:

  • To investigate the frequency and severity of respiratory symptoms in infants with CF compared to healthy controls.
  • To determine if early lung disease markers in CF infants correlate with clinical respiratory symptoms.

Main Methods:

  • Prospective birth cohort study involving 50 infants with CF and 50 matched healthy controls.
  • Standardized weekly interviews documented respiratory symptoms and rates over the first year.
  • Multiple Breath Washout (MBW) was performed in early infancy to assess lung function.

Main Results:

  • Analysis of 4552 data points revealed no significant difference in respiratory symptom frequency between CF and control infants (OR: 1.1; 95% CI: [0.76, 1.59]; p=0.6).
  • Elevated lung clearance index and increased respiratory rate in CF infants were not associated with the presence of respiratory symptoms.
  • Clinical presentation alone may not accurately reflect the extent of early lung disease in infants with CF.

Conclusions:

  • Infants with cystic fibrosis do not exhibit more frequent respiratory symptoms in their first year compared to healthy infants.
  • These findings suggest that subclinical lung disease may be present in early CF, undetectable by clinical observation.
  • Further research is needed to identify reliable early biomarkers for CF lung disease in infancy.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
486
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
291
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.1K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
308
Physical Assessment of the Respiratory Tract II: Inspection01:27

Physical Assessment of the Respiratory Tract II: Inspection

Physical assessment of the respiratory tract through inspection is a crucial step in understanding the patient's respiratory health. It provides insights into the functioning of the respiratory system, the musculoskeletal structure, and even the patient's nutritional status. This comprehensive approach involves observing several vital aspects: chest configuration, breathing patterns, respiratory rates, skin color, and use of accessory muscles.
Chest Configuration
The chest configuration...
527
Respiratory System Abnormal Finding I: Inspection and Percussion01:30

Respiratory System Abnormal Finding I: Inspection and Percussion

Respiratory system abnormalities are a significant concern in healthcare due to their potential to indicate underlying severe conditions like Chronic Obstructive Pulmonary Disease (COPD), asthma, and pneumonia. These abnormalities can often be detected through physical examination methods like inspection and percussion.
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
512